Article

Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to first line ABVD Therapy

2024-01-24

Abstract excerpt

Classic Hodgkin’s lymphoma (cHL) is a curable cancer with disease-free survival rate of over 10 years. Over 80% of diagnosed patients respond favorably to first line chemotherapy. However, 15-20% of patients experience refractory or early relapsed disease. To date, the identification of such patients is still not possible using traditional clinical risk factors. The three-dimensional (3D) telomere analysis has bee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f59508e-04db-511f-afff-40aaa740f5aa
DOI: 10.21203/rs.3.rs-3851546/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to first line ABVD TherapyDOI 10.21203/rs.3.rs-3851546/v1Read

TeloView ® technology predicts genomic instability in chronic lymphocytic leukemiaSemantic proximity Read

Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myelomaSemantic proximity Read

3D-Q-FISH/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/ Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin LymphomaSemantic proximity Read

Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adultsSemantic proximity Read

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.Semantic proximity Read

Integrating TeloView® with Cytogenetics: Biological Characterization of Genomic Instability in CLL Using 3D Telomere ProfilingSemantic proximity Read

Telomere Shortening and Associated Chromosomal Instability in Peripheral Blood Lymphocytes of Patients With Hodgkin’s Lymphoma Prior to Any Treatment Are Predictive of Second CancersSemantic proximity Read

Novel Approaches in Molecular Characterization of Classical Hodgkin LymphomaSemantic proximity Read

Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and PerspectivesSemantic proximity Read

Three-dimensional Telomere Signatures of Hodgkin- and Reed-Sternberg Cells at Diagnosis Identify Patients with Poor Response to Conventional ChemotherapySemantic proximity Read

Solid malignancies in telomere biology disorders.Semantic proximity Read

Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?Semantic proximity Read